LIMK-1 Antibodies

Santa Cruz Biotechnology delivers a wide array of LIMK-1 monoclonal antibodies for research in understanding LIMK-1's role in various cellular processes. LIMK-1 monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LIMK-1, or LIM domain kinase 1, is a crucial regulator of actin dynamics and plays a significant role in cell motility, proliferation, and survival. By phosphorylating cofilin, LIMK-1 modulates actin filament turnover, which is essential for various cellular functions, including migration and morphology. Dysregulation of LIMK-1 has been implicated in several diseases, including cancer and neurodegenerative disorders, making it an important target for therapeutic research. LIMK-1 monoclonal antibodies enable researchers to explore cellular pathways and mechanisms involved in disease progression. Understanding LIMK-1's function through detailed research can lead to potential therapeutic interventions for various pathological conditions. LIMK-1 investigation continues to reveal new insights into cellular regulation and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of LIMK-1's role in health and disease.